Airlift Bioreactors Market Overview
According to the latest research by Future Market Insights, the airlift bioreactor market is set to witness positive growth of CAGR 11% during 2021-2031. The global airlift bioreactors market is expected to be driven by increased research and development for the production of different biochemicals.
Airlift bioreactors are a type of bioreactor in which mixing of the content happens pneumatically using gas. These are used instead of stirred tank bioreactors where mechanical agitation and moving parts are required.
The absence of moving parts reduces the risk of contamination in airlift bioreactors. Hence, making them desirable for the growth of microorganisms. Also, these reactors offer certain advantages over other bioreactors like being more energy efficient and having a less harsh hydrodynamic environment.
What is Driving Demand for Airlift Bioreactors Market?
Airlift bioreactors are used for the production of different biopharmaceuticals products like monoclonal antibodies. These monoclonal antibodies are used for the treatment of many diseases and cancers.
They are also helpful to fight against viruses like SARS-CoV-2. Currently, there is an increase in demand for these products and is expected to increase in the next few years due to the increasing prevalence of viral diseases.
To meet this demand, the companies are investing in building their infrastructure and equipment base. This will drive the market. The airlift bioreactors are also used for vaccine production. The impact of COVID-19 on a global scale has been tremendous. To fight against this deadly virus, vaccines are being manufactured on a large scale. Airlift reactors being a major component of the vaccine producing process, there has been an upsurge in the demand for them in the biopharmaceutical industry in the past two years.
Another driving factor for airlift bioreactors is increasing drug discovery and increasing preference for biologics and biopharma etc. Hence, the demand for medicines will increase and will drive the market.
The other driver for the market is the increase in chronic diseases like cancer, diabetes, heart disease, chronic lung disease etc. According to CDC, in the US 6 out of 10 adults suffer from a chronic disease and this is expected to increase in future. There has been a surge in the research for cancer treatment. This may act as a driver for the market.
Who are the Key Manufacturers and Suppliers of the Airlift Bioreactors Market?
Some of the leading manufacturers and suppliers of airlift bioreactors are
- Sartorius AG
- Shree Biocare
- Knik Technology
- Electrolab Biotech
- Rotech Inc.
- Solida Biotech GmBH
- Zeta GmbH
- Kuhner shaker.
The airlift bioreactor market has many large-scale players available in worldwide markets, and various small-scale participants in specific regional markets like Asia. The growth of the players is mainly focused on various acquisitions and partnerships.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Internal airlift loop bioreactor
- External airlift loop bioreactor
- Stainless steel
- Single-use / disposal
By Production Scale:
- Laboratory scale
- Large scale
- Biopharmaceutical companies
- Contract research organizations (CROs)/ Contract development and manufacturing organizations (CDMOs)
- Research and development companies
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa